Conference abstractPublished 30 Jun 2016
Multistage vector delivery of sulindac and silymarin for prevention of colon cancer
University of Kentucky, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Familiar adenomatous polyposis (FAP) is a genetic condition secondary to germline mutations in the APC gene with a prevalence of one in 10,000 newborns. Patients with this disease will eventually develop colorectal cancer and other cancers of the digestive tract, which typically present themselves in the mid-teens [1]. Prophylactic surgery of the colon is actually the only current standard of care, to avoid malignancy, as long-term exposure to chemo preventive agents such as sulindac (a non-steroidal anti-inflammatory drug) and silymarin (phytoestrogen), usually used to prevent polyps formation in this type of patients, is not feasible. Here, we have used a modified porous silicon-based multistage vector (MSV), rationally designed to deliver therapeutic agents to neoplastic tissue to delivery sulindac and silymarin [11, 12]. Furthermore, the surface of the MSV can be coated with antibodies and other targeting agents that bind to tumor vasculature or neoplastic cells [22, 23]. In this study, MSVs were loaded with poly (ethylene glycol)-block-poly(-caprolactone) (PEG-PCL) micelles encapsulating sulindac or silymarin. Preferential binding and internalization of these drugs into colon cancer cells was obtained using a targeting strategy against the protein meprin A, which is demonstrate, and we confirmed in our work, is overexpressed in human colon cancer cells and in the small intestine of ApcMin/+ mice. We propose that this delivery system could potentially be used to reduce drug-induced side effects in FAP patients, thus enabling long-term prevention of adenoma formation.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Maria Principia Scavo”